REPROCELL and BioBridge Global sign Memorandum of Understanding to accelerate global manufacturing services using clinical iPSCs

Demographics of first-time donors returning for donation during the pandemic: COVID-19 convalescent plasma versus standard blood product donors

Isotyping and quantitation of the humoral immune response to SARS-CoV-2

Sars-CoV2 Antibody Testing: A Comparison of Two Assay Platforms to Designate Convalescent Plasma as High Titer

COVID-19 Convalescent Plasma: One-year Experience

COVID-19 Antibody Testing as a Recruitment Strategy for COVID-19 Convalescent Plasma Donors

Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience

A Review on Currently Available Potential Therapeutic Options for COVID-19

Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients

Treatment of COVID-19 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality

Search
Close this search box.